Bayzed Health (02609): Lv Chao appointed as President
Baize Medical (02609) announced that Mr. Lv Chao (Mr. Lv) was appointed as the President of the company starting from December 29, 2025.
Bayzed Health (02609) announced that Mr. Lv Chao (Mr. Lv) has been appointed as the President of the company starting from December 29, 2025.
The Board of Directors further announced that Dr. Jiang Zheng has resigned as the Assistant President of the company, effective from December 29, 2025, as he wishes to dedicate more time to family matters.
Related Articles
SHOUHUI GROUP (02621) spent HK$67,600 to repurchase 19,600 shares on December 29th.
RECBIO-B(02179): The new drug application for the adjuvanted recombinant herpes zoster vaccine REC610 has been accepted by the National Medical Products Administration.
China Unicom (02671) launched a public offering in Hong Kong with a price cap and received 146.25 times oversubscription.
SHOUHUI GROUP (02621) spent HK$67,600 to repurchase 19,600 shares on December 29th.
RECBIO-B(02179): The new drug application for the adjuvanted recombinant herpes zoster vaccine REC610 has been accepted by the National Medical Products Administration.
China Unicom (02671) launched a public offering in Hong Kong with a price cap and received 146.25 times oversubscription.
